Provenge

Dendreon and Provenge: Too High of a Risk for the Reward
Seeking Alpha
Mon, 08/15/11 - 06:30 pm
prostate cancer
Dendreon
Provenge
JNJ
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Mon, 08/8/11 - 09:18 am
Dendreon
biotech
Provenge
prostate cancer
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Seeking Alpha
Sat, 08/6/11 - 12:59 pm
Dendreon
Provenge
Do Dendreon's Problems Matter to Your Biotech Portfolio?
Seeking Alpha
Sat, 08/6/11 - 12:56 pm
Dendreon
Provenge
Here's Why Dendreon Isn't Like Other Biotechs
Minyanville
Fri, 08/5/11 - 01:55 pm
Dendreon
Provenge
prostate cancer
Dendreon Falls Most Ever After Pulling Sales Forecast on Cancer Therapy
Bloomberg
Thu, 08/4/11 - 04:36 pm
Provenge
Dendreon
prostate cancer
Dendreon CEO Dumped $1M in Stock Before Withdrawing Revenue Guidance
BNET Pharma
Thu, 08/4/11 - 01:09 pm
Dendreon
Provenge
Pharma CEOs
Mitchell Gold
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thu, 08/4/11 - 10:57 am
Dendreon
Provenge
InterMune
Human Genome Sciences
Seattle Genetics
Regeneron
Savient
Dendreon: Parsing Provenge's Problems
TheStreet.com
Thu, 08/4/11 - 09:39 am
Provenge
Dendreon
vaccines
prostate cancer
Dendreon Earnings Preview: It's All About Provenge Sales
Seeking Alpha
Tue, 08/2/11 - 12:44 pm
earnings
Dendreon
Provenge
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Alexa
Gilead Sciences
Regeneron
Dendreon
NuPathe
Provenge
Adcetris
Seattle Genetics
Eyelea
Btripla
Zelrix
AZ-004
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
Dendreon News Could Limit Long Term Upside
Seeking Alpha
Sat, 07/9/11 - 10:56 am
Dendreon
Provenge
prostate cancer
Dendreon climbs 4% in premarket trading
Marketwatch
Fri, 07/1/11 - 09:58 am
Medicare
Dendreon
Provenge
prostate cancer
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
NY Times, NY
Fri, 07/1/11 - 09:55 am
Medicare
Provenge
prostate cancer
Dendreon
Roche
Avastin
breast cancer
Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug
Bloomberg
Thu, 06/30/11 - 07:34 pm
prostate cancer
Dendreon
Provenge
Medicare
Dendreon: Key Catalysts in Play
Seeking Alpha
Mon, 06/27/11 - 08:52 am
Dendreon
prostate cancer
Provenge
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sun, 06/26/11 - 12:03 pm
Dendreon
prostate cancer
DN24-02
Neuvenge
Provenge
Oncothyreon
Stimuvax
colorectal cancer
breast cancer
Keryx
[video]The Next Big Thing In Biotech: Dendreon
TheStreet.com
Fri, 06/24/11 - 10:30 am
Dendreon
Provenge
vaccines
prostate cancer

Pages